▲ Peaking
Health
🔮 fades
Only 13% survive this cancer. A blood test just detected 90% of early cases
A newly validated mRNA blood test is emerging as a diagnostic tool capable of identifying 90% of early-stage pancreatic ductal adenocarcinoma cases.